Meridian Biotechnologies Limited - Abbreviated accounts 16.1

Meridian Biotechnologies Limited - Abbreviated accounts 16.1


03307856 1.4.15 31.3.16 31.3.16 Company accounts Private Limited Company FY true false true false false true false Ordinary 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pure033078562015-03-31033078562016-03-31033078562015-04-012016-03-31033078562014-03-31033078562014-04-012015-03-31033078562015-03-3103307856ns12:England2015-04-012016-03-3103307856ns14:PoundSterling2015-04-012016-03-3103307856ns7:Director12015-04-012016-03-3103307856ns7:OrdinaryShareClass12015-04-012016-03-3103307856ns7:Director22015-04-012016-03-3103307856ns7:Director32015-04-012016-03-3103307856ns7:CompanySecretary2015-04-012016-03-3103307856ns7:RegisteredOffice2015-04-012016-03-3103307856ns7:EntityAccountantsOrAuditors2015-04-012016-03-3103307856ns5:PlantMachinery2015-04-012016-03-3103307856ns7:OrdinaryShareClass12016-03-3103307856ns7:OrdinaryShareClass12015-03-31
REGISTERED NUMBER: 03307856 (England and Wales)














Abbreviated Unaudited Accounts

for the Year Ended 31 March 2016

for

MERIDIAN BIOTECHNOLOGIES LIMITED

MERIDIAN BIOTECHNOLOGIES LIMITED (REGISTERED NUMBER: 03307856)

Contents of the Abbreviated Accounts
FOR THE YEAR ENDED 31 MARCH 2016










Page

Company Information 1

Abbreviated Balance Sheet 2

Notes to the Abbreviated Accounts 4

MERIDIAN BIOTECHNOLOGIES LIMITED

Company Information
FOR THE YEAR ENDED 31 MARCH 2016







DIRECTORS: S P Smyth
S P Temple
J Thomson





SECRETARY: Mrs S C Smyth





REGISTERED OFFICE: Unit 6, Epsom Downs Metro Centre
Waterfield
Tadworth
Surrey
KT20 5LR





REGISTERED NUMBER: 03307856 (England and Wales)





ACCOUNTANTS: Shipleys LLP
Chartered Accountants
3 Godalming Business Centre
Woolsack Way
Godalming
Surrey
GU7 1XW

MERIDIAN BIOTECHNOLOGIES LIMITED (REGISTERED NUMBER: 03307856)

Abbreviated Balance Sheet
31 MARCH 2016

2016 2015
Notes £    £    £    £   
FIXED ASSETS
Intangible assets 2 27,000 29,250
Tangible assets 3 29,588 19,219
56,588 48,469

CURRENT ASSETS
Stocks 165,550 86,161
Debtors 70,015 72,164
Cash at bank 131 2,021
235,696 160,346
CREDITORS
Amounts falling due within one year 145,682 89,073
NET CURRENT ASSETS 90,014 71,273
TOTAL ASSETS LESS CURRENT
LIABILITIES

146,602

119,742

CREDITORS
Amounts falling due after more than one
year

67,085

70,375
NET ASSETS 79,517 49,367

CAPITAL AND RESERVES
Called up share capital 4 100 100
Profit and loss account 79,417 49,267
SHAREHOLDERS' FUNDS 79,517 49,367

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2016.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2016 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies
Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of
each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections
394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial
statements, so far as applicable to the company.

MERIDIAN BIOTECHNOLOGIES LIMITED (REGISTERED NUMBER: 03307856)

Abbreviated Balance Sheet - continued
31 MARCH 2016


The abbreviated accounts have been prepared in accordance with the special provisions of Part 15 of the Companies Act 2006 relating to small companies.


The financial statements were approved by the Board of Directors on 20 December 2016 and were signed on its behalf
by:





S P Smyth - Director


MERIDIAN BIOTECHNOLOGIES LIMITED (REGISTERED NUMBER: 03307856)

Notes to the Abbreviated Accounts
FOR THE YEAR ENDED 31 MARCH 2016


1. ACCOUNTING POLICIES

Accounting convention
The financial statements have been prepared under the historical cost convention and in accordance with the
Financial Reporting Standard for Smaller Entities (effective January 2015).

Exemption from preparing a cash flow statement
Exemption has been taken from preparing a cash flow statement on the grounds that the company qualifies as a
small company.

Turnover
Turnover represents net invoiced sales of goods, excluding value added tax.

Goodwill
Goodwill, being the amount paid in connection with the acquisition of a business in 2008, is being amortised evenly over its estimated useful life of twenty years.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life or, if held under a finance lease, over the lease term, whichever is the shorter.

Plant and machinery etc - 33% on cost and 25% on cost

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow
moving items.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance
sheet date.

Hire purchase and leasing commitments
Assets obtained under hire purchase contracts or finance leases are capitalised in the balance sheet. Those held
under hire purchase contracts are depreciated over their estimated useful lives. Those held under finance leases
are depreciated over their estimated useful lives or the lease term, whichever is the shorter.

The interest element of these obligations is charged to the profit and loss account over the relevant period. The
capital element of the future payments is treated as a liability.

Rentals paid under operating leases are charged to the profit and loss account on a straight line basis over the
period of the lease.

MERIDIAN BIOTECHNOLOGIES LIMITED (REGISTERED NUMBER: 03307856)

Notes to the Abbreviated Accounts - continued
FOR THE YEAR ENDED 31 MARCH 2016


2. INTANGIBLE FIXED ASSETS
Total
£   
COST
At 1 April 2015
and 31 March 2016 45,000
AMORTISATION
At 1 April 2015 15,750
Amortisation for year 2,250
At 31 March 2016 18,000
NET BOOK VALUE

At 31 March 2016 27,000
At 31 March 2015 29,250

3. TANGIBLE FIXED ASSETS
Total
£   
COST
At 1 April 2015 26,641
Additions 20,890
At 31 March 2016 47,531
DEPRECIATION
At 1 April 2015 7,422
Charge for year 10,521
At 31 March 2016 17,943
NET BOOK VALUE
At 31 March 2016 29,588
At 31 March 2015 19,219

4. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 2016 2015
value: £    £   
100 Ordinary £1 100 100